Histologic changes in the rat prostate cancer model after treatment with somatostatin analogs and D‐Trp‐6‐LH‐RH

Growth Factors and Cancer

1991 • 2,044 citations

Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists.

1982 • 364 citations

GROWTH FACTORS AND CANCER

1985 • 352 citations

The effect of estrone-progesterone treatment on cell proliferation kinetics of hormone-dependent GR mouse mammary tumors.

1975 • 218 citations

Synthesis and biological activity of highly potent octapeptide analogs of somatostatin.

1986 • 173 citations

Inhibition of prostate tumor growth in two rat models by chronic administration of D-Trp6 analogue of luteinizing hormone-releasing hormone.

1981 • 149 citations

Long-acting delivery systems for peptides: inhibition of rat prostate tumors by controlled release of [D-Trp6]luteinizing hormone-releasing hormone from injectable microcapsules.

1984 • 144 citations

Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer.

1987 • 104 citations

Radioimmunoassay for 6-D-tryptophan analog of luteinizing hormone-releasing hormone: measurement of serum levels after administration of long-acting microcapsule formulations.

1985 • 46 citations

Chromosomal changes associated with progression of the Dunning R-3327 rat prostatic adenocarcinoma system.

1982 • 45 citations

The presence of LHRH‐like receptors in Dunning R3327H prostate tumors

1983 • 44 citations

Combination of long-acting microcapsules of the D-tryptophan-6 analog of luteinizing hormone-releasing hormone with chemotherapy: investigation in the rat prostate cancer model.

1985 • 38 citations

Investigation of the combination of the agonist D-Trp-6-LH-RH and the antiandrogen flutamide in the treatment of dunning R-3327H prostate cancer model

1985 • 38 citations

Purification and partial characterization of prostate-derived growth factor.

1986 • 36 citations

Androgen, estrogen and progesterone receptors of the R3327H Copenhagen rat prostatic tumor

1979 • 34 citations

Treatment of advanced prostatic carcinoma with D-trp-6-LH-RH

1985 • 27 citations

Treatment of prostatic carcinoma with D‐Trp‐6‐LH‐RH: Plasma hormone levels after daily subcutaneous injections and periodic administration of delayed‐release preparations

1985 • 25 citations

Endocrine, Gastrointestinal, and Antitumor Activity of Somatostatin Analogues

1986 • 22 citations

Combination of a long-acting delivery system for luteinizing hormone-releasing hormone agonist with Novantrone chemotherapy: increased efficacy in the rat prostate cancer model.

1986 • 17 citations

Histological findings in the rat prostate cancer model during treatment with a luteinizing hormone‐releasing hormone agonist and novantrone

1987 • 5 citations

Role of prolactin in modulating the effects of tamoxifen on growth of the dunning R3327 rat prostate adenocarcinoma

1987 • 4 citations

Hormonal and Chemotherapeutic Treatment of Prostatic Carcinoma; Dunning Adenocarcinoma of the Prostate in Copenhagen-Fischer Rats

1985 • 3 citations

Proliferation of dunning R‐3327 rat prostatic adenocarcinoma and of its sublines (CUA and CUB)

1986 • 3 citations

Stability of Sublines in the R3327-H Rat Prostatic Tumor

1986 • 2 citations